Saint David Hospice, Inc Medicare Approved Location: 10999 Riverside Drive, Ste 306, Toluca Lake, California 91602 Phone: (818) 781-4005 |
News Archive
A new study by researchers at Oxford University examines neurological and psychiatric outcomes in recovered COVID-19 patients six months post-infection.
Dr. Peter J. Hotez, an internationally recognized clinician and investigator of neglected tropical diseases and vaccine development, will be giving a lecture at the University of Houston (UH) from 3 to 4 p.m. Friday, Feb. 10. Hotez is one of many prominent scientists with broad appeal who will be hosted by UH in support of the university's health initiative. The talk is free and open to the public.
Individuals between 30 and 80 years of age, who have had a transient ischemic attack (TIA) or non-severe stroke within the past 30 days, and who cannot be treated surgically, may be eligible to participate in a Phase III clinical trial of a minimally invasive stenting procedure at the Cedars-Sinai Neurovascular Center. The study will focus specifically on patients who have had an intracranial artery narrowed by at least 70 percent and who are experiencing recurrent strokes or TIAs despite being on anti-clotting medication.
In recent years, RNA molecules, with the ability to affect or turn off pathogenic genes, have become promising drug candidates in several areas.
Unexpectedly, inflammation markers do not appear to be involved with the chemopreventative effect of aspirin on colorectal adenomas, according to a brief communication published online October 12 in the Journal of the National Cancer Institute.
› Verified 6 days ago